PLAKEDOR Trademark

Trademark Overview

On Wednesday, April 21, 2010, a trademark application was filed for PLAKEDOR with the United States Patent and Trademark Office. The USPTO has given the PLAKEDOR trademark a serial number of 85019588. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 14, 2020. This trademark is owned by Glaxo Group Limited. The PLAKEDOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
plakedor

General Information

Serial Number85019588
Word MarkPLAKEDOR
Filing DateWednesday, April 21, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 14, 2020
Registration Number4460738
Registration DateTuesday, January 7, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe word(s) "PLAKEDOR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, August 14, 2020CANCELLED SEC. 8 (6-YR)
Monday, January 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 7, 2014REGISTERED-PRINCIPAL REGISTER
Friday, November 29, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 25, 2013NOTICE OF ALLOWANCE CANCELLED
Monday, November 25, 2013TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2013EXTENSION 5 GRANTED
Wednesday, June 19, 2013EXTENSION 5 FILED
Friday, July 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 19, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2012EXTENSION 4 GRANTED
Friday, December 7, 2012EXTENSION 4 FILED
Friday, December 7, 2012TEAS EXTENSION RECEIVED
Thursday, June 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 27, 2012EXTENSION 3 GRANTED
Monday, June 25, 2012EXTENSION 3 FILED
Monday, June 25, 2012TEAS EXTENSION RECEIVED
Friday, January 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2012EXTENSION 2 GRANTED
Friday, December 16, 2011EXTENSION 2 FILED
Thursday, January 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 16, 2011TEAS EXTENSION RECEIVED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2011EXTENSION 1 GRANTED
Wednesday, June 15, 2011EXTENSION 1 FILED
Wednesday, June 15, 2011TEAS EXTENSION RECEIVED
Tuesday, December 28, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2010PUBLISHED FOR OPPOSITION
Friday, September 24, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 13, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 10, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 10, 2010ASSIGNED TO LIE
Wednesday, August 25, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 27, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2010NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2010NON-FINAL ACTION WRITTEN
Tuesday, July 27, 2010ASSIGNED TO EXAMINER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 24, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

plakedor pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic